Home » Topics » Regulatory

Regulatory
RSS

Gilead files NDA for new cidofovir formulation

Jan. 7, 1997

Improved formulation of Vanceril approved for market

Jan. 7, 1997

Mentax approved for two new indications by FDA

Jan. 7, 1997

FDA clears Rogaine generic

Jan. 3, 1997

Procrit cleared for new indication

Jan. 3, 1997

New HRT patch approved for launch in U.S.

Jan. 3, 1997

Generic antidiabetic agent approved by FDA

Jan. 3, 1997

Andrx freed to market Dilacor XR bioequivalent

Jan. 3, 1997

Watson's first NDA product approved

Jan. 3, 1997

Two FDA approvals for Taro

Jan. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...